Navigation Links
Perrigo Reports Record Second Quarter Sales
Date:2/3/2009

ting corporate expenses and removing underperforming products and assets. It is imperative that we not rest on OTC's strong performance alone, but rather continue to look for additional ways to drive return on invested capital and to position ourselves for any environment."

"As a result of the combination of these factors, we are now expecting adjusted fiscal 2009 earnings to be between $1.75 and $1.90 per share, which implies a year over year growth rate of adjusted earnings of 11 to 20% over fiscal 2008. This is down from our previous guidance of $1.92 to $2.00 per share, excluding charges outlined in Table III at the end of this release. Reported fiscal 2009 earnings per share are expected to be between $1.55 and $1.70 per share."

"Looking ahead, we believe Perrigo is well positioned to continue to add value to our customers and shareholders."

Perrigo will host a conference call to discuss fiscal 2009 second quarter results at 10:00 a.m. (ET) on Tuesday, February 3. The conference call will be available live via webcast to interested parties on the Perrigo website http://www.perrigo.com or by phone 877-248-9413, International 973-582-2737 and reference ID# 80886866. A taped replay of the call will be available beginning at approximately 2:00 p.m. (ET) Tuesday, February 3, until midnight Friday, February 13, 2009. To listen to the replay, call 800-642-1687, International 706-645-9291, access code 80886866.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing and logistics operations are the Unit
'/>"/>

SOURCE Perrigo Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Perrigo Company Announces Quarterly Dividend
2. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
3. Perrigo Company Will Release Second Quarter Fiscal Year 2009 Results on February 3, 2009
4. Perrigo Company to Present at the 27th Annual JPMorgan Healthcare Conference
5. Perrigo Announces FDA Final Approval for Ibuprofen PM
6. Perrigo Settles Desloratadine Patent Litigation
7. Perrigo Acknowledges Settlement of NASACORT(R) AQ Nasal Spray Patent Litigation
8. Perrigo Announces FDA Tentative Approval for Ibuprofen PM
9. Perrigo Company Licenses Prescription Brands to Medimetriks Pharmaceuticals
10. Perrigo Company To Present at the Merrill Lynch Global Pharmaceutical Conference
11. Perrigo Begins Shipments of Famotidine Complete to Customers Nationwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Line: Patients with advanced laryngeal cancer appear to ... surgery than nonsurgical chemoradiation. , Author: Uchechukwu C. ... Medicine at Mount Sinai, New York, and colleagues. ... laryngeal cancer are diagnosed each year and squamous ... these tumors. Prior to 1991, total surgical removal ...
(Date:8/21/2014)... Improv performers from Fun House Theatre and ... Silverado Turtle Creek memory care community in Dallas. The ... from ages 10 to 16, delivers a groundbreaking and ... The troupe's philosophy is that improv is based on ... touch audiences regardless of their circumstance — including bringing ...
(Date:8/21/2014)... have pinpointed the environmental source of fungal infections that ... decades. It literally grows on trees. , The discovery ... girl, who spent the summer gathering soil and tree ... infections of the fungus named Cryptococcus gattii ... encompasses a number of species including C. gattii ...
(Date:8/21/2014)... California (PRWEB) August 21, 2014 The ... initial plans for entertainment and programming for its inaugural ... On Sunday, October 12, 2014, from 11 a.m. to ... closed to all cars and the downtown will be ... activities, curated by Community Arts Resources (CARS), for all ...
(Date:8/21/2014)... Aug. 21, 2014 (HealthDay News) -- Not only is eating ... save them hundreds of health-care dollars a year, a new ... professor of public health sciences at Wake Forest Baptist Medical ... and obese type 2 diabetes patients. Participants ... assigned to either an intensive "lifestyle change program" focused on ...
Breaking Medicine News(10 mins):Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 3Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 4Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2
... PURCHASE, N.Y., March 30 Nutrition 21 is ... and Chief Executive Officer, has been elected to ... Products Association (CHPA). CHPA is a 128-year ... over-the-counter medicines and nutritional supplement products. Members ...
... Year According to the Better Sleep CouncilDALLAS, March 30 ... is usually one of the first things people scrimp on ... turbulent economy, nearly 30 percent of Americans lose sleep ... a 2009 Sleep in America poll by the National Sleep ...
... A health insurance protocol intended to ... barriers that lead people to receive less of needed ... result, patients ultimately require more -- and more costly ... plan members to try a first-line medication before they ...
... of chronic illnesses in Europe and the consequent ... has amplified the need for equipment that measure ... This rise in the number of people requiring ... and transducers.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )New analysis from ...
... Q-Stress and Q-Tel cardiac rehab to healthcare information ... CSCX ), a global leader in ... today added DICOM connectivity to its Quinton Q-Stress ... rehabilitation system. "With DICOM and HL7 technologies, Cardiac ...
... Kachmann teaches how the connection between mind, body ... Ind., March 30 For residents of Ft. ... Kachmann Mind Body Institute ( www.kachmannmindbody.com ) noted ... health and the arts. Now, having retained award-winning ...
Cached Medicine News:Health News:Nutrition 21's President and CEO, Elected to the Consumer Healthcare Products Association Board 2Health News:Nutrition 21's President and CEO, Elected to the Consumer Healthcare Products Association Board 3Health News:It Pays to Sleep: Prioritize Rest to Boost Health, Morale and Revenue 2Health News:It Pays to Sleep: Prioritize Rest to Boost Health, Morale and Revenue 3Health News:Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers 2Health News:Thomson Reuters Study Finds Step Therapy Programs May Increase Overall Healthcare Costs for Employers 3Health News:Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan 2Health News:Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan 3Health News:Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan 4Health News:Cardiac Science Connects to EMR, HIS, PACS Systems Using DICOM and HL7 Technologies 2Health News:Cardiac Science Connects to EMR, HIS, PACS Systems Using DICOM and HL7 Technologies 3Health News:Cardiac Science Connects to EMR, HIS, PACS Systems Using DICOM and HL7 Technologies 4Health News:Dr. Rudy Kachmann, Neurosurgeon, Author, Lecturer & Founder of Kachmann Mind Body Institute Selects TransMedia Group as Agency of Record 2
(Date:8/21/2014)... 2014 /CNW/ - Bedrocan Cannabis Corp., previously Bedrocan Canada ... its Board of Directors, enhancing executive oversight and ... a leading licensed producer of medicinal cannabis in ... 13 years, experience in producing and supplying government-regulated ... Canada. As previously announced in ...
(Date:8/21/2014)... (NASDAQ: CYBX ) today announced results for the ... 1   Operating results for the first quarter ... 2014, and other achievements, include: , Worldwide net product ... Strong international net sales of $13.2 million, an increase of ... product sales reached a new high of $58.8 million, an ...
(Date:8/21/2014)... 2014 Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a ... medicine, announced today the appointments of Andrew ("Andy") Arno ... Board of Directors. With these additions, the Asterias Board ... are independent. Andy Arno , 55, ... companies. He is currently Managing Director of Emerging Growth ...
Breaking Medicine Technology:Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4
... SANTA MARIA, Calif., Feb. 14, 2011 Hardy Diagnostics, ... the release of HardyCHROM™ SS, a highly selective chromogenic ... for the isolation and differentiation of Salmonella ... two pathogens can be easily distinguished from non-pathogenic enteric ...
... MedQuist Holdings Inc. (Nasdaq: MEDH ), formerly ... documentation solutions for the U.S. healthcare system, today announced ... shares of its common stock.  The shares began trading ... under the ticker symbol MEDH. In ...
Cached Medicine Technology:The Only Chromogenic Medium That Detects Both Salmonella and Shigella! 2MedQuist Holdings Inc. Announces Closing of Its Initial U.S. Public Offering and Acquisition of Additional Shares of MedQuist Inc. 2MedQuist Holdings Inc. Announces Closing of Its Initial U.S. Public Offering and Acquisition of Additional Shares of MedQuist Inc. 3
Nidek offers 3-Dx Digital stereo camera to provide a complete and comprehensive digital imaging platform....
Measurement of progressive multi-focal lenses is fast and easy with the CLM-3000 auto-lensmeter. The data is represented in a simple to understand bar graphic display....
Auto Lensmeter LM-970...
Autolensmeter with black/white monitor and no internal printer....
Medicine Products: